Dr. Lin serves as a Guest Professor of Fujian Medical University (FMU) for many years and currently is the Vice-President of the Institute of Immunotherapy, FMU. He, along with his American and Chinese colleagues, established an antibody engineering facility that is dedicated to the small-scale production of therapeutic monoclonal antibodies for head and neck cancer and others. The facility has been used to produce many therapeutic monoclonal antibodies and facilitate research and teaching relevant to cancer immunotherapy. Dr. Lin is interested in the immune and inflammatory aspects of head and neck squamous cell carcinoma, with a focus on the immunotherapy of head and neck squamous cell carcinoma.